citalopram hydrobromide

Generic: citalopram hydrobromide

Labeler: glenmark therapeutics inc., usa
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name citalopram hydrobromide
Generic Name citalopram hydrobromide
Labeler glenmark therapeutics inc., usa
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

citalopram hydrobromide 40 mg/1

Manufacturer
Glenmark Therapeutics Inc., USA

Identifiers & Regulatory

Product NDC 72657-111
Product ID 72657-111_c5c89eef-6b45-4dc7-8c88-89d972a3e4b5
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA077654
Listing Expiration 2026-12-31
Marketing Start 2022-01-13

Pharmacologic Class

Classes
serotonin reuptake inhibitor [epc] serotonin uptake inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72657111
Hyphenated Format 72657-111

Supplemental Identifiers

RxCUI
200371 283672 309314
UPC
0372657111010 0372657109017 0372657110013
UNII
I1E9D14F36

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name citalopram hydrobromide (source: ndc)
Generic Name citalopram hydrobromide (source: ndc)
Application Number ANDA077654 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 40 mg/1
source: ndc
Packaging
  • 100 TABLET, FILM COATED in 1 BOTTLE (72657-111-01)
  • 500 TABLET, FILM COATED in 1 BOTTLE (72657-111-05)
source: ndc

Packages (2)

Ingredients (1)

citalopram hydrobromide (40 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "c5c89eef-6b45-4dc7-8c88-89d972a3e4b5", "openfda": {"upc": ["0372657111010", "0372657109017", "0372657110013"], "unii": ["I1E9D14F36"], "rxcui": ["200371", "283672", "309314"], "spl_set_id": ["18330b41-27ad-461b-a0a9-aac94e8ee87f"], "manufacturer_name": ["Glenmark Therapeutics Inc., USA"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED in 1 BOTTLE (72657-111-01)", "package_ndc": "72657-111-01", "marketing_start_date": "20220113"}, {"sample": false, "description": "500 TABLET, FILM COATED in 1 BOTTLE (72657-111-05)", "package_ndc": "72657-111-05", "marketing_start_date": "20220113"}], "brand_name": "Citalopram Hydrobromide", "product_id": "72657-111_c5c89eef-6b45-4dc7-8c88-89d972a3e4b5", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Serotonin Reuptake Inhibitor [EPC]", "Serotonin Uptake Inhibitors [MoA]"], "product_ndc": "72657-111", "generic_name": "Citalopram Hydrobromide", "labeler_name": "Glenmark Therapeutics Inc., USA", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Citalopram Hydrobromide", "active_ingredients": [{"name": "CITALOPRAM HYDROBROMIDE", "strength": "40 mg/1"}], "application_number": "ANDA077654", "marketing_category": "ANDA", "marketing_start_date": "20220113", "listing_expiration_date": "20261231"}